Studies of bioactivity, conformation and pharmacokinetic profiles of site-specific PEGylated thymosin alpha 1 derivatives.
Jiankun Qie, Jinbo Ma, Liangyou Wang, Xiaoyu Xu, Jianquan Zheng, Sijian Dong, Jianwei Xie, Huixian Sun, Wenxia Zhou, Chunhui Qi, Xiunan Zhao, Yongxiang Zhang, Keliang Liu
Index: Drug Metab. Lett. 1 , 232-240, (2007)
Full Text: HTML
Abstract
Site-specific mono-PEGylations were performed in different conformational regions of Thymosin alpha 1 (T alpha 1) by introducing one cysteine residue into the chosen site and coupling with thiol-specific mPEG-MAL reagent. Results demonstrated that PEGylated sites and regions influenced the conformations and pharmacokinetic profiles of the peptide greatly with following order: alpha-helix, beta-turn, random coil and terminals, but little on the immunoactivity.
Related Compounds
Related Articles:
Site-directed pegylation of recombinant interleukin-2 at its glycosylation site.
1990-04-01
[Biotechnology 8 , 343-346, (1990)]
Analysis of functionalization of methoxy-PEG as maleimide-PEG.
2008-03-15
[Anal. Biochem. 374 , 231-242, (2008)]
2016-01-01
[Sci. Rep. 6 , 27484, (2016)]